Literature DB >> 11781836

Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.

P N Nair1, D T De Armond, M L Adamo, W E Strodel, J W Freeman.   

Abstract

In the present study we investigated the mechanisms responsible for and the biological consequences of the constitutive activation of the insulin-like growth factor-1 receptor (IGF-1R) in the MIA PaCa-2 cells. An aberrant increase in the expression and activation of the IGF-1R was observed during the transition of growth states from exponential to quiescent. The increase in IGF-1R expression is preceded by an increase in IGF-1R mRNA transcript and is associated with an increase in the IGF-1R promoter activity. Inhibition of de novo transcription by actinomycin D increased the stability of IGF-1R mRNA in exponentially growing cells, thereby increasing the expression of IGF-1R to a level similar to that seen in quiescent cells. Increased IGF-1R signaling mediated the growth factor independence of quiescent MIA PaCa-2 cells through the constitutive activation of mitogen-activated protein kinase (MAPK). Exogenous IGF-1 increased cell proliferation and activated MAPK and AKT signaling pathways. The resistance of cells to apoptosis by IGF-1R signaling was mediated through MAPK and phosphatidylinositol 3-kinase (PI3K) pathways and a yet unidentified pathway(s). Thus, aberrant regulation of IGF-1R signaling is required for resistance to apoptosis and growth factor independence of MIA PaCa-2 cells. This likely protects cells from unfavorable conditions and allows cells to rapidly re-enter the cell cycle when conditions are favorable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781836     DOI: 10.1038/sj.onc.1205044

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.

Authors:  Roberto Bellucci; Hong-Nam Nguyen; Allison Martin; Stefan Heinrichs; Anna C Schinzel; William C Hahn; Jerome Ritz
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

Review 2.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

Review 3.  Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics.

Authors:  Manti Guha; Narayan G Avadhani
Journal:  Mitochondrion       Date:  2013-09-01       Impact factor: 4.160

4.  Personalized therapy for pancreatic cancer: Myth or reality in 2010?

Authors:  Tzu-Chuan Jane Huang; Siddhartha Kar; Milind Javle
Journal:  J Gastrointest Oncol       Date:  2010-09

Review 5.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

6.  Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

7.  Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Fan Fan; Christine Wagner; Kathrin Stengel; Ray J Somcio; Niels Reinmuth; Alexander A Parikh; Daniel J Hicklin; Lee M Ellis
Journal:  Cancer Lett       Date:  2007-10-22       Impact factor: 8.679

8.  Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth.

Authors:  Sarah K Johnson; Randy S Haun
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Alexander A Parikh; Corazon D Bucana; Douglas B Evans; Gregg L Semenza; Lee M Ellis
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 10.  Molecular therapeutics in pancreas cancer.

Authors:  Vignesh Narayanan; Colin D Weekes
Journal:  World J Gastrointest Oncol       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.